Publication | Closed Access

In vitro activity of oritavancin (LY333328), vancomycin, clindamycin, and metronidazole against Clostridium perfringens, Propionibacterium acnes, and anaerobic Gram-positive cocci

Antimicrobial SusceptibilityAntibioticsMedicineAntibacterial AgentAntimicrobial TherapyMicrobiologyAntimicrobial ChemotherapyAntimicrobial CompoundAnaerobic Gram-positive CocciPharmacologyClinical MicrobiologyAntimicrobial ResistancePropionibacterium AcnesVitro Activity